how to minimize glp-1 side effects Part 2 of a 3-Part Series; Medications for Weight Loss Struggling with GLP-1 therapy side

Noom reports 70% of microdosing members experience no side effects, potentially improving long-term adherence

This blog draws from insights shared during our recent webinar on payer perspectives on GLP-1 therapies, using data from our 2025 Trends in Drug Benefit Design Report

However, the above-linked study doesn't appear to be published in any peer-reviewed journals

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) Diabetes Care

and 146,330 (8.1%) were diagnosed with OSA and prescribed a GLP-1

Whether the same will extend to humans remains to be seen, but the authors claim their study "provides a strategy for diabetes prevention." The study was published in Nature Microbiology